123 related articles for article (PubMed ID: 34243839)
1. Catalog of Age- and Medical Condition-Specific Healthcare Costs in the United States to Inform Future Costs Calculations in Cost-Effectiveness Analysis.
Jiao B; Basu A
Value Health; 2021 Jul; 24(7):957-965. PubMed ID: 34243839
[TBL] [Abstract][Full Text] [Related]
2. The Economic Burden of Asthma in the United States, 2008-2013.
Nurmagambetov T; Kuwahara R; Garbe P
Ann Am Thorac Soc; 2018 Mar; 15(3):348-356. PubMed ID: 29323930
[TBL] [Abstract][Full Text] [Related]
3. Trends in Healthcare Expenditures Among US Adults With Hypertension: National Estimates, 2003-2014.
Kirkland EB; Heincelman M; Bishu KG; Schumann SO; Schreiner A; Axon RN; Mauldin PD; Moran WP
J Am Heart Assoc; 2018 May; 7(11):. PubMed ID: 29848493
[TBL] [Abstract][Full Text] [Related]
4. Cost of disorders of the brain in Europe 2010.
Gustavsson A; Svensson M; Jacobi F; Allgulander C; Alonso J; Beghi E; Dodel R; Ekman M; Faravelli C; Fratiglioni L; Gannon B; Jones DH; Jennum P; Jordanova A; Jönsson L; Karampampa K; Knapp M; Kobelt G; Kurth T; Lieb R; Linde M; Ljungcrantz C; Maercker A; Melin B; Moscarelli M; Musayev A; Norwood F; Preisig M; Pugliatti M; Rehm J; Salvador-Carulla L; Schlehofer B; Simon R; Steinhausen HC; Stovner LJ; Vallat JM; Van den Bergh P; van Os J; Vos P; Xu W; Wittchen HU; Jönsson B; Olesen J;
Eur Neuropsychopharmacol; 2011 Oct; 21(10):718-79. PubMed ID: 21924589
[TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness of drotrecogin alfa (activated) in the treatment of severe sepsis.
Angus DC; Linde-Zwirble WT; Clermont G; Ball DE; Basson BR; Ely EW; Laterre PF; Vincent JL; Bernard G; van Hout B;
Crit Care Med; 2003 Jan; 31(1):1-11. PubMed ID: 12544986
[TBL] [Abstract][Full Text] [Related]
6. Exploring the cost-effectiveness of child dental caries prevention programmes. Are we comparing apples and oranges?
Anopa Y; Conway DI
Evid Based Dent; 2020 Mar; 21(1):5-7. PubMed ID: 32221482
[TBL] [Abstract][Full Text] [Related]
7. Estimating the Economic Burden of Acute Myocardial Infarction in the US: 12 Year National Data.
Bishu KG; Lekoubou A; Kirkland E; Schumann SO; Schreiner A; Heincelman M; Moran WP; Mauldin PD
Am J Med Sci; 2020 May; 359(5):257-265. PubMed ID: 32265010
[TBL] [Abstract][Full Text] [Related]
8. Standardizing the inclusion of indirect medical costs in economic evaluations.
van Baal PH; Wong A; Slobbe LC; Polder JJ; Brouwer WB; de Wit GA
Pharmacoeconomics; 2011 Mar; 29(3):175-87. PubMed ID: 21184618
[TBL] [Abstract][Full Text] [Related]
9. Estimating annual medical and out-of-pocket expenditures associated with traumatic injuries in the United States.
Alghnam S; Vanness DJ; Gaskin DJ; Thorpe RJ; Castillo R
J Trauma Acute Care Surg; 2016 Feb; 80(2):258-64. PubMed ID: 26517784
[TBL] [Abstract][Full Text] [Related]
10. Cost-Effectiveness of Cancer Screening: Health and Costs in Life Years Gained.
Ratushnyak S; Hoogendoorn M; van Baal PHM
Am J Prev Med; 2019 Dec; 57(6):792-799. PubMed ID: 31753260
[TBL] [Abstract][Full Text] [Related]
11. Healthcare Costs Among Patients with Heart Failure: A Comparison of Costs between Matched Decedent and Survivor Cohorts.
Obi EN; Swindle JP; Turner SJ; Russo PA; Altan A
Adv Ther; 2017 Jan; 34(1):261-276. PubMed ID: 27933568
[TBL] [Abstract][Full Text] [Related]
12. Short-term persistence of high health care costs in a nationally representative sample of children.
Liptak GS; Shone LP; Auinger P; Dick AW; Ryan SA; Szilagyi PG
Pediatrics; 2006 Oct; 118(4):e1001-9. PubMed ID: 17015496
[TBL] [Abstract][Full Text] [Related]
13. Health system costs by sex, age and proximity to death, and implications for estimation of future expenditure.
Blakely T; Atkinson J; Kvizhinadze G; Nghiem N; McLeod H; Wilson N
N Z Med J; 2014 May; 127(1393):12-25. PubMed ID: 24816953
[TBL] [Abstract][Full Text] [Related]
14. Rising annual costs of dizziness presentations to U.S. emergency departments.
Saber Tehrani AS; Coughlan D; Hsieh YH; Mantokoudis G; Korley FK; Kerber KA; Frick KD; Newman-Toker DE
Acad Emerg Med; 2013 Jul; 20(7):689-96. PubMed ID: 23859582
[TBL] [Abstract][Full Text] [Related]
15. Effect of future costs on cost-effectiveness of medical interventions among young adults: the example of intensive therapy for type 1 diabetes mellitus.
Meltzer D; Egleston B; Stoffel D; Dasbach E
Med Care; 2000 Jun; 38(6):679-85. PubMed ID: 10843315
[TBL] [Abstract][Full Text] [Related]
16. Costs and cost-drivers of a diagnosis of depression among adults with epilepsy in the United States.
Lekoubou A; Bishu KG; Ovbiagele B
Epilepsy Behav; 2019 Sep; 98(Pt A):96-100. PubMed ID: 31301456
[TBL] [Abstract][Full Text] [Related]
17. The healthcare costs of sarcopenia in the United States.
Janssen I; Shepard DS; Katzmarzyk PT; Roubenoff R
J Am Geriatr Soc; 2004 Jan; 52(1):80-5. PubMed ID: 14687319
[TBL] [Abstract][Full Text] [Related]
18. [Healthcare expenditure and the impact of age: a detailed analysis for survivors and decedents].
Stahmeyer JT; Hamp S; Zeidler J; Eberhard S
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2021 Oct; 64(10):1307-1314. PubMed ID: 34258630
[TBL] [Abstract][Full Text] [Related]
19. Trends in Costs of Depression in Adults with Diabetes in the United States: Medical Expenditure Panel Survey, 2004-2011.
Egede LE; Walker RJ; Bishu K; Dismuke CE
J Gen Intern Med; 2016 Jun; 31(6):615-22. PubMed ID: 26969312
[TBL] [Abstract][Full Text] [Related]
20. The economic burden of vision loss and eye disorders among the United States population younger than 40 years.
Wittenborn JS; Zhang X; Feagan CW; Crouse WL; Shrestha S; Kemper AR; Hoerger TJ; Saaddine JB;
Ophthalmology; 2013 Sep; 120(9):1728-35. PubMed ID: 23631946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
